These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa. Graf P. Clin Ther; 1999 Oct; 21(10):1749-55. PubMed ID: 10566570 [Abstract] [Full Text] [Related]
3. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment. Graf P, Hallén H. ORL J Otorhinolaryngol Relat Spec; 1997 Oct; 59(1):39-44. PubMed ID: 9104748 [Abstract] [Full Text] [Related]
4. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling. Graf P, Juto JE. Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314 [Abstract] [Full Text] [Related]
5. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Graf P, Hallén H. Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089 [Abstract] [Full Text] [Related]
13. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR. Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657 [Abstract] [Full Text] [Related]
14. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal. Graf PM, Hallén H. Am J Rhinol; 1997 Sep; 11(1):67-72. PubMed ID: 9065350 [Abstract] [Full Text] [Related]